Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma

Published:2018-04-16 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Karamitros Timokratis,Papatheodoridis George,Paraskevis Dimitrios,Hatzakis Angelos,Mbisa Jean L.,Georgopoulou Urania,Klenerman Paul,Magiorkinis Gkikas

Funder

Medical Research Council

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference56 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

3. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants;Funk;J Viral Hepat,2002

4. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review;Papatheodoridis;J Hepatol,2012

5. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment;Hadziyannis;Semin Liver Dis,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi‐omics approach and prognostic model development;Journal of Cellular and Molecular Medicine;2024-04

2. Association Between Past Hepatitis B Infection and abdominal aorta calcification: National Health and Nutrition Examination Survey;2023-05-05

3. Pharmacogenetic Biomarkers of Protein Therapeutics;Protein-based Therapeutics;2023

4. Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma;Microorganisms;2022-01-24

5. Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis;Hepatology;2021-05-21